1/22/2024 0 Comments Jing zhang illinois![]() On the investment side, Jing has assisted in preparing several notices to the Committee on Foreign Investment in the US (CFIUS) and securing for clients national security approvals by the US government. Her work includes advising US and foreign corporations on their trade compliance obligations, handling daily US export control and sanctions questions, and advising clients facing government investigation risks or adverse administrative actions. Jing also advises clients on export control, sanctions and related national security restrictions on trade. She also counsels clients on invalidity proceedings at the United States Patent and Trademark Office, including inter partes reviews. She advises clients on all aspects of litigation strategy, discovery, trial preparation, and post-trial filings. ![]() Jing regularly collaborates with the firm’s Intellectual Property (IP) group and has represented Chinese companies in several IP litigations before the ITC and federal courts. ![]() She also routinely analyzes obligations and defenses under WTO Agreements and advises clients on matters related to Section 301 tariffs. In AD and CVD matters, Jing defends foreign producers and US importers against US unfair trade allegations as lead counsel, before the US Department of Commerce, the US International Trade Commission (ITC) and federal courts. She assists major US and foreign corporations in focused assessments (customs audits), compliance surveys or reviews and other proceedings before US Customs & Border Protection. She advises clients on a wide range of international trade matters, including antidumping (AD), anti-subsidy (CVD), export control, sanctions, intellectual property and customs matters, with a substantial focus on advising multinational companies on cross-border compliance issues involving China. All Rights Reserved.Jing Zhang is a partner in Mayer Brown’s International Trade group. boulardii.Ĭopyright © 2016, American Society for Microbiology. boulardii can be performed without using a drug resistance marker, which is a prerequisite for in vivo applications using engineeredS. boulardii Our results suggest that more sophisticated genetic perturbations to improveS. boulardii We further demonstrated that human lysozyme, which is beneficial for human gut health, could be secreted by S. cerevisiae We demonstrated the overexpression of a heterologous gene (lacZ), the correct localization of a target protein (red fluorescent protein) into mitochondria by using a protein localization signal, and the introduction of a heterologous metabolic pathway (xylose-assimilating pathway) in the genome ofS. ![]() ![]() The resulting auxotrophic mutants can be used as a host for introducing various genetic perturbations, such as overexpression or deletion of a target gene, using existing genetic tools forS. Here, we report the development of well-defined auxotrophic mutants (leu2,ura3,his3, and trp1) through clustered regularly interspaced short palindromic repeat (CRISPR)-Cas9-based genome editing. However, the lack of auxotrophic strains with defined genetic backgrounds has hampered the use of this strain for metabolic engineering. boulardiiis an attractive host for metabolic engineering to produce biomolecules of interest in the gut. This yeast not only exhibits beneficial phenotypes for gut health but also can stay longer in the gut than Saccharomyces cerevisiae Therefore, S. Saccharomyces boulardiiis a probiotic yeast that has been used for promoting gut health as well as preventing diarrheal diseases. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |